How much does a box of Adagraxibu cost?

Adagrasib (Adagrasib) is a prescription drug designed for adults and plays an important role in the fight against cancer. Adagrasiib has shown unique benefits for those with non-small cell lung cancer (NSCLC), especially when the cancer has spread to other parts of the body or cannot be removed with surgery.

It is particularly worth mentioning that this drug is particularly effective for patients with abnormalKRAS G12C genes in their tumors. Such patients have often experienced at least one treatment, but their disease has not been effectively controlled. Adagrasiib doesn't stop there. When combined with cetuximab, it can also fight colon or rectal cancer (CRC) that has spread to other parts of the body or cannot be removed with surgery. This combination therapy provides new treatment opportunities for patients who have previously received other chemotherapy drugs with poor response.

Adagrasib is not currently on the market in China, so it cannot be included in domestic medical insurance reimbursement items. It is understood that the first generic drug of adagrasibu has recently been launched on the market in Laos. This global innovative action has ignited new hope for patients and families who have no choice but to give up treatment because they cannot afford the high price of the original drug. This generic drug of adagrasibu produced in Laos has successfully challenged the price hegemony of the original drug, reducing the cost of treatment from the original high price of 200,000 yuan per month to only 8,000 to 9,000 yuan per month. For patients who have any questions about adagrasib, it is recommended to seek help from professional overseas medical consulting agencies.

Overall, adagrasib, with its unique pharmacological effects and wide range of indications, brings valuable hope and options to patients who are in a difficult battle against cancer.